Management of concomitant central venous disease

Symptomatic central venous disease (CVD) is a significant common problem in patients with end-stage renal disease given its adverse impact on hemodialysis (HD) vascular access (VA). The current mainstay management is percutaneous transluminal angioplasty (PTA) with or without stenting which is typic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnahhal, Khaled I., Rowse, Jarrad, Kirksey, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article on Endovascular and Surgical Interventions in the End Stage Renal Disease Population
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971306/
https://www.ncbi.nlm.nih.gov/pubmed/36864954
http://dx.doi.org/10.21037/cdt-22-570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971306/
https://www.ncbi.nlm.nih.gov/pubmed/36864954
http://dx.doi.org/10.21037/cdt-22-570

Ejemplares similares